ABSTRACT
INTRODUCTION
The incidence of patients with end-stage renal failure and type 2 diabetes mellitus as a comorbid condition has increased progressively in the past decades, first in the United States and Japan, but subsequently in all countries with a western lifestyle. 1 Causes of renal disease might vary from one population to another e.g. in Saudi Arabia. It had been reported to be relatively high and was thought probably due to a cultural practice that might increase the incidence of genetic renal disease, the intermarriage among cousins and other close relatives. Similarly other factors of renal disease include hypertension, chronic glomerulonephritis, diabetes, an kidney stones.
The prevalence of diabetes mellitus (DM) caused heavy economic burden to health-care providers, the annual mortality among dialysis patients remained high, reaching 22% in USA, 14 .4% in Europe, and 11% in Saudi Arabia. 3 There was no data available on the incidence of diabetic renal disease in Saudi diabetics. It was known that vast majority of Saudi diabetics entering dialysis (96%) were of Type II. 4 In Saudi Arabia DM increased from 4.9% in 1985 to 7.4% in 1995 5 , there were 700 patients on hemodialysis at the end of 2001, the annual rate of increase in number of these patients was 9.7% and it was projected that by the year of 2015 there will be more than 13,000 patients on dialysis in the Kingdom. 6 Our objective was to study the clinical profile of diabetic patients with ESRD undergoing hemodialysis at the Al-noor Specialist Hospital, Makkah, with a view of identifying common clinical factors.
METHODOLOGY
This descriptive study was done in the nephrology unit of Al-noor specialist hospital a teaching tertiary care referral unit in the Makkah region, Saudi Arabia. Its dialysis unit had been established on 1409hijra (1989G), and started with only seven dialysis machines but now it has eighty-one. The data had been collected in the month of Shawal of 1426hijra (corresponding to 13-11-2005 to 12-12-2005) , from patients' files, dialysis charts and also from diabetic patients directly, who were on regular dialysis treatment.
Medical files and dialysis charts were reviewed for Socio-demographic data, duration of illnesses and clinical profile of subjects with associated macro-vascular complications, ie coronary artery disease, cerebrovascular & peripheral vascular disease, gastrointestinal, eg gastropareses and diarrhea, dermatological and genitourinary dysfunctions, eg uropathy and sexual dysfunction. Micro-vascular complications were also reviewed regarding eye, eg retinopathy, macular edema, cataract, glaucoma, and neuropathy and nephropathy. 7 Subjects' age groups were divided into decades. At the time of study, latest values of glucose level, lipid profile were collected from record. Blood sugar (random) level, total cholesterol level, 8 low density lipoprotein level and triglyceride level, >200mg/dl, >200mg/dl, >130mg/dl and >165mg/dl respectively were considered as high. 7 The information about history of smoking, family history and anti diabetic treatment was collected from patients directly.
Similarly type of diabetes had also been confirmed by inquiring from patients the age of diagnosis of diabetes as well as mode of treatment started at the time of diagnosis and current medication at the time of data collection. The whole data had been analyzed to show the age of onset of diabetes as well as dialysis, duration of diabetes as well as dialysis, and the time spent from start of diabetes to dialysis.
Data was analysed by using SPSS version 13. Simple Chi-squared test was applied to nominal, ordinal and binary categorical data. Measurement data was subjected to descriptive analysis as well as two sample t-Test assuming equal variance to find significance of difference in mean values of metabolic profile between two sexes. P-value <0.05 was considered significant.
RESULTS
Total of 253 patients with ESRD was on regular dialysis in the study period. Out of them 57(22.5%) were diabetic (X 2 =75.2, p<0.001). Six diabetics were pulled out from study because four had lack of follow up, one was expired and one had lack of required data. Males were 31(60.8%) and all were Saudis. Maximum patients 23(45.1%) were in 6 th decade of life. Non-smokers were 29(56.9%). Almost 38(74.5%) patients had family history of diabetes. Table-II and III. Clinical profile showed that 27(52.9%) subjects had only diabetic nephropathy without any other complications. Patients of Type-2 DM were (78.4%). Only one male patient had low density lipoprotein (LDL) level <130mg/dl while 41(80%) had glucose level <200mg/dl. Dialysis was the only management of diabetic control in 30(58.8%) patients. The range of glucose was 148-193mg/dl for the subjects with controlled DM by dialysis only. Almost all of the subjects were hypertensive and were on antihypertensive treatment. Table-IV. 
DISCUSSION
End-stage renal failure requiring dialysis is one of the most serious complications of diabetes mellitus. 9 The average annual incidence rate of dialysis was 12 times greater in persons with diabetes than without diabetes. By 1999-2000, diabetic patients comprised 51% of the dialysis population. 9 The average annual prevalence rate was 10 times greater in the diabetic cohort. Patients with diabetes had more co-morbidity at the start of dialysis and poorer three year survival (55 vs. 68%; P < 0.0001). The incidence and prevalence rates of dialysis for patients with diabetes mellitus are many times the rates of those Zohair Jamil Gazzaz et al. without diabetes. Patients with diabetes mellitus often start dialysis with significant co-morbidities, which may contribute to the relatively high rate of mortality on dialysis. 9 A number of cross-sectional studies have confirmed that the susceptibility to ESRD due to non-diabetic renal disease is increased in subjects of African and Indo-Asian descent. 10 In our unit during the study period 253 patients were on dialysis while in 1982, according to Jondeby, there were 370 patients receiving dialysis in KSA, in 1999 the number increased to 5706, with 2084 new patients entering dialysis in 1999 alone. The mean age increased from 37.9 to 51.3 years, respectively. In the early 1980s, Jondeby reported DM as a cause of end-stage renal disease in only (4%) of the patients 11 but in our unit (22.5%) patients developed ESRD due to DM also contrary to Qari, 
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Of all diabetics entering dialysis, non-insulin dependent DM accounted for (78.4%) in our unit compared to (96%) in the study of Ismail 16 and Sunagawa 17 while Brazda had shown (28.6%). 12 Our study showed male predominance similar to the studies of Qari 5 , Sunagawa 17 and Whorra 18 , but contrary to the study of Foucani. Type 2 diabetes and hypertension are commonly associated conditions, both of which carry an increased risk of cardiovascular and renal disease. The prevalence of hypertension in type 2 diabetes is higher than that in the general population, especially in younger patients. Hypertension increases the already high risk of cardiovascular disease associated with type 2 diabetes. 21 Another factor was that there is diminishing mortality from hypertension and cardiovascular causes, so that patients survive long enough to develop nephropathy and endstage renal failure. 1 The mean age of diabetic patients in our study is more than those of Qari 5 and Ma 22 . Similarly mean duration of dialysis in our study was (22.1 months) which was higher than those of Ma 22 , Qari 5 and Whorra. 18 The mean age of start of dialysis in our study was lesser than that of Qari 5 (46.5yrs) and Foucan 14 (60.6yrs). Our study had also shown prominent dyslipidemia. It is noted that out of the study group, (71.2%) had been started on heamodialysis within sixteen to twenty years of being diagnosed to have diabetes, suggesting either a delay in the diagnosis of disease or the presence of other factors leading to acceleration of diabetic nephropathy like dyslipidemia, hypertension.
The prevalence of both acute and chronic renal failure is high in the Arab world. Data available on the exact prevalence of various renal diseases is very limited. Nevertheless, the reported prevalence of chronic renal failure is 80 to 120 per million populations (pmp) in the Kingdom of Saudi Arabia and 225 pmp in Egypt. This is in comparison with the reported prevalence of 283 pmp in Europe, 975 pmp in the United States, and 1149 pmp in Japan. Lower prevalence rates reported in this region could be due to underreporting. Paradoxically, in the Arab world, we have a good opportunity to reduce the incidence of kidney failure (chronic and acute) because many of the causes of renal failure are eminently preventable. It is worthy of mention that, in the Arab world, the budget for research is about 0.15% of the national domestic product compared with the international average of (1.5%).
23
Limitations of the study: This study was limited to hospital based and had the data of Haemodialysis patients with diabetic nephropathy leading to ESRD only diabetic patients who were on regular haemodialysis since last three months of start of study. Subjects who developed ESRD due to other reasons were excluded. Other umra visitor patients who were admitted for dialysis not on regular bases were also excluded. Study duration is limited to only one month which did not give true picture of new cases. HbA1c which is a good reflector of diabetes control could not be measured. Latest glucose and lipid profile was collected rather than to calculate the mean values of last three months of these investigations Similarly outcome of subjects were not followed as more complications occurred due to catheterization which could worsen the condition.
CONCLUSIONS
In conclusion, diabetes is an important cause of ESRD in Saudi patients undergoing chronic HD at Al-Noor Specialist Hospital. This may be attributed to poor control of diabetes, hypertension as well as inadequate early screening. Improved care of diabetes and aggressive management of hypertension with good follow up throughout on regular basis can reduce or delay prevalence and improve good prognosis of diabetic nephropathy.
